BZBodi Zhang

Bodi Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bodi Zhang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers

    Mast cells and inflammation

    by Theoharis C. Theoharides, Konstantinos-Dionysios Alysandratos, Asimenia Angelidou, Danae-Anastasia Delivanis, Nikolaos Sismanopoulos, Bodi Zhang, Shahrzad Asadi, Magdalini Vasiadi, Zuyi Weng, Alexandra Miniati, et al.


  • Open Access

    Mitochondrial DNA and anti-mitochondrial antibodies in serum of autistic children

    by Bodi Zhang, Asimenia Angelidou, Konstantinos-Dionysios Alysandratos, Magdalini Vasiadi, Konstantinos Francis, Shahrzad Asadi, Athanasios Theoharides, Kyriaki Sideri, Lefteris Lykouras, Dimitrios Kalogeromitros, et al.

    Autism spectrum disorders (ASD) are neurodevelopmental disorders characterized by difficulties in communication, cognitive and learning deficits, as well as stereotypic behaviors. For the majority of cases there are no reliable biomarkers or distinct pathogenesis. However, increasing evidence indicates ASD may be associated with some immune dysregulation, and may have a neuroimmune component. We recently showed that the peptide neurotensin (NT) is increased in autistic children. We now show that NT induces release of extracellular mitochondrial DNA (mtDNA) that could act as "autoimmune" trigger. We further show that serum from young autistic patients contains mtDNA (n = 20; cytochrome B, p = 0.0002 and 7S, p = 0.006), and anti-mitochondrial antibody Type 2 (n = 14; p = 0.001) as compared to normally developing, unrelated controls (n = 12). Extracellular blood mtDNA and other components may characterize an autistic endophenotype and may contribute to its pathogenesis by activating autoimmune responses.


  • Open Access

    Neurotensin is increased in serum of young children with autistic disorder

    by Asimenia Angelidou, Konstantinos Francis, Magdalini Vasiadi, Konstantinos-Dionysios Alysandratos, Bodi Zhang, Athanasios Theoharides, Lefteris Lykouras, Kyriaki Sideri, Dimitrios Kalogeromitros, Theoharis C Theoharides

    Autism spectrum disorders (ASD) are a group of pervasive neurodevelopmental disorders diagnosed in early childhood. They are associated with a set of "core symptoms" that include disabilities in social interaction skills, verbal and non-verbal communication, as well as repetitive and stereotypic behaviors. There is no definite pathogenetic mechanism or diagnostic tests. Many children with ASD also have "allergic-like" symptoms, but test negative implying mast cell activation by non-allergic triggers. We measured by Milliplex arrays serum levels of 3 neuropeptides that could stimulate mast cells in children with autistic disorder (n = 19; 16 males and 3 females; mean age 3.0 ± 0.4 years) and healthy, unrelated controls (n = 16; 13 males and 3 females; mean age 3 ± 1.2 years). Only neurotensin (NT) was significantly increased from 60.5 ± 6.0 pg/ml in controls to 105.6 ± 12.4 pg/ml in autistic disorder (p = 0.004). There was no statistically significant difference in the serum levels of β-endorphin or substance P (SP). NT could stimulate immune cells, especially mast cells, and/or have direct effects on brain inflammation and ASD.